Nanobiotix SA (EUR)
NANO
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range5.43 | 6.35
52-Wk Range |
Last Close6.02
Mkt Cap (m)134.75
Dividend yield-
ISINFR0011341205
Volume826,769
Exchange VenuePAR

Company Profile

Nanobiotix SA is engaged in the development of NanoXray, a pipeline of patented products, which are based on a physical mechanism of action. It develops tools for cancer, which utilize a physical mode of action at the cellular level of the cancer cell.

Key Information
Price/Earning-
Price/Book6.50
Price/Sales36.27
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Annual Report
en 31/12/2015

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)24543-
Operating Income (m)-10-17-22-25-9-
Net Income (m)-10-17-22-26-30-
Basic EPS-0.74-1.20-1.43-1.50-1.55-
Avg. Diluted Shares Outstanding (m)1314151720-
Balance Sheet
EUR201420152016201720182019
Current Assets (m)3623275343-
Non Current Assets (m)23444-
Total Assets (m)3726305746-
Current Liabilities (m)478912-
Total Liabilities (m)------
Total Equity (m)3016174414-
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)-9-17-18-21-26-
Capital Expenditure (m)-----1-
Figures are quoted in EUR unless stated otherwise
-
No change
6.02
Last Price